Table of Contents

Select this article
- M I Wiggam,
- M J O'Kane,
- R Harper,
- A B Atkinson,
- D R Hadden,
- E R Trimble,
- and P M Bell
Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.
Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347
- Abstract
Select this article
- H Ilkova,
- B Glaser,
- A Tunçkale,
- N Bagriaçik,
- and E Cerasi
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
Diabetes Care September 1997 20:1353-1356; doi:10.2337/diacare.20.9.1353
- Abstract
Select this article
- D Kumar
Lispro analog for treatment of generalized allergy to human insulin.
Diabetes Care September 1997 20:1357-1359; doi:10.2337/diacare.20.9.1357
- Abstract
Select this article
- V Bril,
- J Kojic,
- M Ngo,
- and K Clark
Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies.
Diabetes Care September 1997 20:1360-1362; doi:10.2337/diacare.20.9.1360
- Abstract
Select this article
- A D Morris,
- D I Boyle,
- A D McMahon,
- H Pearce,
- J M Evans,
- R W Newton,
- R T Jung,
- and T M MacDonald
ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit.
Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363
- Abstract
Select this article
- T T Lao and
- K F Tam
Maternal serum ferritin and gestational impaired glucose tolerance.
Diabetes Care September 1997 20:1368-1369; doi:10.2337/diacare.20.9.1368
- Abstract
Select this article
- F J Méndez and
- M Beléndez
Effects of a behavioral intervention on treatment adherence and stress management in adolescents with IDDM.
Diabetes Care September 1997 20:1370-1375; doi:10.2337/diacare.20.9.1370
- Abstract
Select this article
- M K Mau,
- A Grandinetti,
- R F Arakaki,
- H K Chang,
- E K Kinney,
- and J D Curb
The insulin resistance syndrome in native Hawaiians. Native Hawaiian Health Research (NHHR) Project.
Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376
- Abstract
Select this article
- J I Barzilay,
- R A Kronmal,
- V Bittner,
- E Eaker,
- C Evans,
- and E D Foster
Coronary artery disease in diabetic patients with lower-extremity arterial disease: disease characteristics and survival. A report from the Coronary Artery Surgery Study (CASS) registry.
Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381
- Abstract
Select this article
- P K Elias,
- M F Elias,
- R B D'Agostino,
- L A Cupples,
- P W Wilson,
- H Silbershatz,
- and P A Wolf
NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.
Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388
- Abstract
Select this article
- J V Selby,
- G T Ray,
- D Zhang,
- and C J Colby
Excess costs of medical care for patients with diabetes in a managed care population.
Diabetes Care September 1997 20:1396-1402; doi:10.2337/diacare.20.9.1396
- Abstract
Select this article
- S J Feeney,
- M A Myers,
- I R Mackay,
- P Z Zimmet,
- N Howard,
- C F Verge,
- and M J Rowley
Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.
Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403
- Abstract
Select this article
- A J Hanley,
- S B Harris,
- X J Gao,
- J Kwan,
- and B Zinman
Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM.
Diabetes Care September 1997 20:1408-1415; doi:10.2337/diacare.20.9.1408
- Abstract
Select this article
- A M Wawryk,
- D J Bates,
- and J J Couper
Power spectral analysis of heart rate variability in children and adolescents with IDDM.
Diabetes Care September 1997 20:1416-1421; doi:10.2337/diacare.20.9.1416
- Abstract
Select this article
- S B Harris,
- L E Caulfield,
- M E Sugamori,
- E A Whalen,
- and B Henning
The epidemiology of diabetes in pregnant Native Canadians. A risk profile.
Diabetes Care September 1997 20:1422-1425; doi:10.2337/diacare.20.9.1422
- Abstract
Select this article
- F J Service,
- P C O'Brien,
- S D Wise,
- S Ness,
- and S M LeBlanc
Dermal interstitial glucose as an indicator of ambient glycemia.
Diabetes Care September 1997 20:1426-1429; doi:10.2337/diacare.20.9.1426
- Abstract
Select this article
- S M Haffner,
- M Hanefeld,
- S Fischer,
- K Fuçker,
- and W Leonhardt
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.
Diabetes Care September 1997 20:1430-1434; doi:10.2337/diacare.20.9.1430
- Abstract
Select this article
- T M Davis,
- I M Stratton,
- C J Fox,
- R R Holman,
- and R C Turner
U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435
- Abstract
Select this article
- K Kobayashi,
- S Amemiya,
- E Sawanobori,
- K Higashida,
- T Ishihara,
- K Kobayashi,
- K Kato,
- and S Nakazawa
Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM.
Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442
- Abstract
Select this article
- E A Davis,
- T W Jones,
- P Walsh,
- and G C Byrne
The use of biothesiometry to detect neuropathy in children and adolescents with IDDM.
Diabetes Care September 1997 20:1448-1453; doi:10.2337/diacare.20.9.1448
- Abstract
Select this article
- L L Vitelli,
- E Shahar,
- G Heiss,
- P G McGovern,
- F L Brancati,
- J H Eckfeldt,
- and A R Folsom
Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study.
Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454
- Abstract
Select this article
- A Caixas,
- A Pérez,
- J Qrdóñez-Llanos,
- R Bonet,
- M Rigla,
- A Castellví,
- L Bayen,
- and A de Leiva
Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients.
Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459
- Abstract
Select this article
- M Carantoni,
- F Abbasi,
- L Chu,
- Y D Chen,
- G M Reaven,
- P S Tsao,
- B Varasteh,
- and J P Cooke
Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM.
Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462
- Abstract
Select this article
- Y Hamada,
- J Nakamura,
- H Fujisawa,
- H Yago,
- E Nakashima,
- N Koh,
- and N Hotta
Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients.
Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466
- Abstract
Select this article
- E Sivan,
- X Chen,
- C J Homko,
- E A Reece,
- and G Boden
Longitudinal study of carbohydrate metabolism in healthy obese pregnant women.
Diabetes Care September 1997 20:1470-1475; doi:10.2337/diacare.20.9.1470
- Abstract
Select this article
- M W Schwartz,
- R L Prigeon,
- S E Kahn,
- M Nicolson,
- J Moore,
- A Morawiecki,
- E J Boyko,
- and D Porte, Jr
Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms.
Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476
- Abstract
Select this article
- A Faas,
- F G Schellevis,
- and J T Van Eijk
The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review.
Diabetes Care September 1997 20:1482-1486; doi:10.2337/diacare.20.9.1482
- Abstract
- Z T Bloomgarden
Topics in type 2 diabetes.
Diabetes Care September 1997 20:1487-1490
- T Kazumi,
- T Hozumi,
- Y Ishida,
- and G Yoshino
Insulin responses to oral glucose during 4-year treatment with nifedipine retard in hypertensive patients with and without NIDDM.
Diabetes Care September 1997 20:1491
- J C Sanchez-Thorin
Retinopathy and type 2 diabetes.
Diabetes Care September 1997 20:1491-1493
- A I Pincelli,
- C Grispigni,
- A Parafioriti,
- and M de Pellegrin
Involvement of the musculotendinous apparatus in flexion contractures of limited joint mobility of the diabetic hand.
Diabetes Care September 1997 20:1493-1495
- T E Strandberg
Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease.
Diabetes Care September 1997 20:1495-1496
- J C Pickup,
- G A Roberts,
- A M Kehely,
- C Pasapula,
- G D Chusney,
- and H M Mather
Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women.
Diabetes Care September 1997 20:1496
- R Matz
Outcomes in diabetic patients.
Diabetes Care September 1997 20:1497-1498

Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

Lispro analog for treatment of generalized allergy to human insulin.

Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies.

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit.

Maternal serum ferritin and gestational impaired glucose tolerance.

Effects of a behavioral intervention on treatment adherence and stress management in adolescents with IDDM.

The insulin resistance syndrome in native Hawaiians. Native Hawaiian Health Research (NHHR) Project.

Coronary artery disease in diabetic patients with lower-extremity arterial disease: disease characteristics and survival. A report from the Coronary Artery Surgery Study (CASS) registry.

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.

Excess costs of medical care for patients with diabetes in a managed care population.

Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.

Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM.

Power spectral analysis of heart rate variability in children and adolescents with IDDM.

The epidemiology of diabetes in pregnant Native Canadians. A risk profile.

Dermal interstitial glucose as an indicator of ambient glycemia.

Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.

Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM.

The use of biothesiometry to detect neuropathy in children and adolescents with IDDM.

Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study.

Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients.

Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM.

Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients.

Longitudinal study of carbohydrate metabolism in healthy obese pregnant women.

Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms.

The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review.

Topics in type 2 diabetes.

Insulin responses to oral glucose during 4-year treatment with nifedipine retard in hypertensive patients with and without NIDDM.

Retinopathy and type 2 diabetes.

Involvement of the musculotendinous apparatus in flexion contractures of limited joint mobility of the diabetic hand.

Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease.

Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women.

Outcomes in diabetic patients.

This Issue

Current Issue

From the Cover